Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

By Johnson Clint  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 889-898

Springer Publishing Company

Access to resources Recommend Favorite

Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer: results of a multinational study

By Thomas D.B.   Ray R.M.   Qin Q.  

Cancer Causes and Control, Vol. 13, Iss. 7, 2002-09 ,pp. : 683-690

Springer Publishing Company

Access to resources Recommend Favorite

Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer

By Sousa Hugo   Oliveira Sara   Santos Alexandra   Catarino Raquel   Moutinho José   Medeiros Rui  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2561-2564

Springer Publishing Company

Access to resources Recommend Favorite

Antibody Levels against -Galactosyl Epitopes in Sera of Patients with Squamous Intraepithelial Lesions and Early Invasive Cervical Carcinoma

By Tremont-Lukats I.W.   Avila J.L.   Hernandez D.   Vasquez J.   Teixeira G.M.   Rojas M.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 207-212

Elsevier

Access to resources Recommend Favorite

Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions

By Daneri-Navarro A.   Macias-Lopez G.   Oceguera-Villanueva A.   Del Toro-Arreola S.   Bravo-Cuellar A.   Perez-Montfort R.   Orbach-Arbouys S.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 566-569

Elsevier

Access to resources Recommend Favorite